Received Sep 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Vertigo; This spontaneous case was reported by a physician and describes the occurrence of VERTIGO (Vertigo) in a female patient of an unknown age who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: COVID vaccine (had vertigo once before 3 days after receiving a Covid Vaccine). Past adverse reactions to the above products included Vertigo with COVID vaccine. In 2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (unknown route) 1 dosage form. In 2025, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown. The action taken with mRNA-1273.251 (Spikevax LP.8.1 PFS) (Unknown) was unknown. For mRNA-1273.251 (Spikevax LP.8.1 PFS) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. Patient woke up during the night with vertigo after receiving the vaccine. Patient have had this issue once before and when looked back through the patient's records, it turned out that during that time, it occurred 3 days after receiving a Covid vaccine. It was reported that probably it might be a coincidence, but it gave the patient a pause. When patient looked it up, the patient could not find anything conclusive. Treatment information was not reported. This case was linked to MOD-2025-789132 (Patient Link).